We are pleased to announce that Aagami has received Contract Extension and Expansion of scope from its US based client. The client is an Awa...
Published : 20 Feb 2024
Read MoreWe are pleased to announce that Aagami CEO Dinesh Jain will be attending DCAT Week 2023 in person from MARCH 18 to 21 in New York City. If you or your...
Published : 09 Feb 2024
Read MoreSeveral months back, a Biosimilar focused subsidiary of a Global Pharma had appointed Aagami to help out-license their Market ready Denosumab Biosimil...
Published : 19 Jan 2024
Read MoreWe are pleased to announce that Aagami has received contract extension from its Japan and US based client. Client is a nose to brain [NtoB]...
Published : 10 Jan 2024
Read MoreHappy with the delivery of the first Assignment, our US based client has now appointed Aagami for Acquisition/Partnering for their Patented s...
Published : 12 Dec 2023
Read MoreContinuing with its annual tradition, Aagami completed an action packed and productive Bio Europe in Munich (Nov 6-8, 2023). This time Aagami and...
Published : 14 Nov 2023
Read MoreJP Morgan Healthcare (JPM) week is an annual pilgrimage for Aagami and hence the team is already geared up for participation including Biotech Showcas...
Published : 22 Oct 2023
Read MoreA US based Innovator has appointed Aagami for evaluation of his Intellectual Property of two patent families and the underlying technology. The o...
Published : 27 Aug 2023
Read MoreAagami has a new client. This time it is a new subsidiary of an existing client from New York. The new client is focused on understanding the rol...
Published : 21 Aug 2023
Read MoreWe are glad to announce that Aagami is attending the International Life Sciences Partnering Conference – BIO-Europe® 2023 (November ...
Published : 17 Aug 2023
Read More